Huolun Feng

机构：Guangdong General Hospital, Guangdong Academy of Sciences, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Southern Medical University · ORCID：0009-0004-4315-3039

发表论文 63 篇 · 总被引 429 次 · h-index 10

代表论文

• EZH2 inhibition and 5-azacytidine enhance antitumor immunity in PTEN-deficient glioblastoma by activation viral mimicry response (2025 · Journal for ImmunoTherapy of Cancer · 被引 9)
• Tumor-Derived CCL16 Normalizes Tumor Vasculature through Macrophage ICAM-1 Receptor and Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma (2025 · Cancer Research · 被引 7)
• Specific loading of oncolytic VSV on CAR enhances CAR-T cell signaling and antitumor activity (2025 · The Journal of Experimental Medicine · 被引 7)
• Targeting TBK1 potentiates oncolytic virotherapy via amplifying ICAM1-mediated NK cell immunity in chemo-resistant colorectal cancer (2025 · Journal for ImmunoTherapy of Cancer · 被引 6)
• Stenotrophomonas promotes gastrointestinal tumor progression via STING degradation in tumour cells and mitigated immune response (2026 · Nature Communications · 被引 3)
• Clonal hematopoiesis of indeterminate potential and the risk of breast cancer: a UK Biobank cohort study (2025 · International Journal of Surgery · 被引 3)